Business
Sana Biotechnology to Present at September 2023 Investor Conferences
SEATTLE, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered
About this update from Sana Biotechnology, Inc.
[{"type":"text","content":"SEATTLE, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at five investor conferences in September. The presentations will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer, and Nate Hardy, Sana’s Chief Financial Officer. Steve Harr will present at Citi’s 18th Annual BioPharma Conference at 10:30 a.m. ET on Wednesday, September 6, 2023.Steve Harr will present at the 2023 Wells Fargo Healthcare Conference at 2:15 p.m. ET on Thursday, September 7, 2023.Nate Hardy will present at the HC Wainwright 25th Annual Global Investment Conference at 10:00 a.m. ET on Monday, September 11, 2023.Steve Harr will present at the Morgan Stanley 21st Annual Healthcare Conference at 1:35 p.m. ET on Tuesday, September 12, 2023.Nate Hardy will present at the 2023 Cantor Global Healthcare Conference at 10:55 a.m. ET on Wednesday, September 27, 2023. The webcasts will be accessible on the Investor Relations page of Sana’s website at https://sana.com/. A replay of each presentation will be available at the same location for 30 days following the corresponding conference. About Sana BiotechnologySana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are a passionate group of people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, South San Francisco, and Rochester. For more information about Sana Biotechnology, please visit https://sana.com/. Cautionary Note Regarding Forward-Looking StatementsThis press release contains forward-looking statements about Sana Biotechnology, Inc. (the “Company,” “we,” “us,” or “our”) within the meaning of the federal securities laws, including those related to the Company’s vision; the Company’s participation at Citi’s 18th Annual BioPharma Conference, the 2023 Wells Fargo Healthcare Conference, the HC Wainwright 25th Annual Global Investment Conference, the Morgan Stanley 21st Annual Healthcare Conference, and the 2023 Cantor Global H...